201 related articles for article (PubMed ID: 29683741)
1. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
[TBL] [Abstract][Full Text] [Related]
2. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
3. Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change.
Bertoglio S
J Vasc Access; 2021 Sep; 22(5):689-691. PubMed ID: 32962527
[TBL] [Abstract][Full Text] [Related]
4. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
Goossens GA; Stas M; Moons P
Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
[TBL] [Abstract][Full Text] [Related]
5. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
He J
J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
[TBL] [Abstract][Full Text] [Related]
6. Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely: A Systematic Review and Meta-analysis.
Clari M; Spoto M; Franceschi G; Acuto M; Tonella S; Caristia S; Buratti G; Gaboardi S; Rasero L; Campagna S; Busca E; Dal Molin A
Cancer Nurs; 2021 May-Jun 01; 44(3):205-213. PubMed ID: 32384421
[TBL] [Abstract][Full Text] [Related]
7. Technology of flushing vascular access devices.
Hadaway L
J Infus Nurs; 2006; 29(3):137-45. PubMed ID: 16878855
[TBL] [Abstract][Full Text] [Related]
8. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
9. Prolonged flushing and locking interval for totally implantable vascular access device: A systematic review and meta-analysis.
Xiong ZY; Zhou HM; Li SY
J Vasc Access; 2021 Nov; 22(6):969-978. PubMed ID: 33752495
[TBL] [Abstract][Full Text] [Related]
10. Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.
Dal Molin A; Clerico M; Baccini M; Guerretta L; Sartorello B; Rasero L
Eur J Oncol Nurs; 2015 Dec; 19(6):638-43. PubMed ID: 25933709
[TBL] [Abstract][Full Text] [Related]
11. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
[TBL] [Abstract][Full Text] [Related]
12. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
[TBL] [Abstract][Full Text] [Related]
13. [Implantable venous access ports, nursing practices].
Ourliac M; Dijols-Lécuyer I
Soins; 2016 May; (805):17-20. PubMed ID: 27157553
[TBL] [Abstract][Full Text] [Related]
14. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of totally implantable venous access devices.
Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
[TBL] [Abstract][Full Text] [Related]
16. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
Ghayyda SN; Roland D; Cade A
J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
[TBL] [Abstract][Full Text] [Related]
17. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
18. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
19. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
